ArticleCureus2023
Incidence of Preeclampsia and Cesarean Section Rate According to the Robson Classification.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Association between diagnostic criteria of preeclampsia with severe features and adverse perinatal outcomes.American journal of obstetrics & gynecology MFM · 2026Article
- Gestational Weight Gain and Its Association With Preeclampsia and Blood Pressure Trends: A Retrospective Cohort Study.The Australian & New Zealand journal of obstetrics & gynaecology · 2026Article
- Hemodynamic Changes During Cesarean Section Under Spinal Anesthesia in Normotensive and Hypertensive Pregnant Women-A Narrative Review.Journal of clinical medicine · 2026Review
- Association of Pre-Eclampsia with Intraoperative Hemodynamics and Postoperative Complications in Cesarean Delivery Under General Anesthesia: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Article
- Cesarean Section Trend in a University Hospital in Thailand.Journal of pregnancy · 2026Article
- Preeclampsia among Omani women: prevalence and associated risk factors.Frontiers in global women's health · 2026Article
- Health system drivers of caesarean deliveries in south Asia: a scoping review.The Lancet regional health. Southeast Asia · 2025Review
- Machine Learning Approach to Predict Emergency Cesarean Sections Among Nulliparous Women.Cureus · 2025Article
- Perinatal Outcomes Among Patients Using OB Teleflex, A Hybrid Prenatal Telemedicine Program.Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2025Article
- Timing and mode of birth for women with sickle cell disease: A systematic review.Pregnancy (Hoboken, N.J.) · 2025Review
- Combined assessment of placental growth factor, uterine artery pulsation index, and mean arterial pressure for predicting preeclampsia.American journal of translational research · 2025Article
- Article
- Maternal and neonatal outcomes associated with preeclampsia among Omani women: A restrospective unmatched case control study.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives The objective of this study was to determine the incidence of preeclampsia and associated cesarean section (CS) rate according to the Robson classification. Methods A retrospective cross-sectional study was conducted on a total of 670 women who delivered at a tertiary care hospital in Thailand during January to March 2023. All women were classified into 10 groups according to the Robson classification, and preeclampsia was identified. Overall and group-specific incidence of preeclampsia and CS rate were estimated. Comparison of CS rate was made between those with and without preeclampsia using the Chi-squared test. Relative risks (RR) and corresponding 95% confidence intervals were estimated. Results The majority of women were in group 1 (34%) and group 3 (30.7%). Overall CS rate was 40.6% with highest contribution from group 1, 5, and 10. Incidence of preeclampsia was 9.1%, and the majority were in groups 10 (29.5%) and 1 (23%). Preeclampsia significantly increased the rate of overall CS (RR 1.8, p<0.001). The risk of CS significantly increased in group 1 (RR 1.8, p=0.043), group 3 (RR 3.5, p=0.025), and group 10 (RR 1.9, p=0.006). Preeclampsia accounted for 15.4% of all CS, with the highest contribution in group 2 (37.5%), group 10 (31.1%), group 3 (16.7%), and group 1 (10.8%). Without preeclampsia, the overall CS rate was relatively reduced by 6.9%, with the largest relative reduction in group 10 (14.3%), group 3 (11.5%), group 2 (6.3%), and group 1 (5.2%). Conclusion The incidence of preeclampsia was 9.1%, and preeclampsia significantly increased the rate of overall CS. Without preeclampsia, overall CS rate relatively reduced by 6.9% but did not significantly change the relative contribution of CS according to the Robson classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.